Vanguard Group Inc Daxor Corp Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Daxor Corp stock. As of the latest transaction made, Vanguard Group Inc holds 48,828 shares of DXR stock, worth $351,073. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,828
Previous 48,828
-0.0%
Holding current value
$351,073
Previous $422,000
11.14%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DXR
# of Institutions
11Shares Held
90.3KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8KShares$106,5620.0% of portfolio
-
Keyes, Stange & Wooten Wealth Management, LLC Palm Coast, FL14.6KShares$105,0600.07% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ7.2KShares$51,7680.0% of portfolio
-
Sbi Securities Co., Ltd. Tokyo, M03.13KShares$22,4900.0% of portfolio
-
Ubs Group Ag1.24KShares$8,8860.0% of portfolio
About DAXOR CORP
- Ticker DXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 4,041,670
- Market Cap $29.1M
- Description
- Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used i...